Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 173
of 9Next
1:

Immunotherapy of type 1 diabetes: lessons for other autoimmune diseases.

Bach JF.

Arthritis Res. 2002;4 Suppl 3:S3-15. Epub 2002 May 9. Review.

PMID: 12110118 [PubMed - indexed for MEDLINE]

2:

Diabetes intervention therapy.

Maclaren NK.

J Diabetes Complications. 1993 Apr-Jun;7(2):151-6. Review.

PMID: 8518457 [PubMed - indexed for MEDLINE]

3:

Anti-4-1BB-based immunotherapy for autoimmune diabetes: lessons from a transgenic non-obese diabetic (NOD) model.

Sytwu HK, Lin WD, Roffler SR, Hung JT, Sung HS, Wang CH, Cheng TL, Tsou SC, Hsi SC, Shen KL.

J Autoimmun. 2003 Nov;21(3):247-54.

PMID: 14599849 [PubMed - indexed for MEDLINE]

4:

Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases.

Alyanakian MA, You S, Damotte D, Gouarin C, Esling A, Garcia C, Havouis S, Chatenoud L, Bach JF.

Proc Natl Acad Sci U S A. 2003 Dec 23;100(26):15806-11. Epub 2003 Dec 12. Erratum in: Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4331.

PMID: 14673094 [PubMed - indexed for MEDLINE]

5:

CD3 antibody treatment stimulates the functional capability of regulatory T cells.

Chatenoud L.

Novartis Found Symp. 2003;252:279-86; discussion 286-90. Review.

PMID: 14609225 [PubMed - indexed for MEDLINE]

6:

Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment.

You S, Leforban B, Garcia C, Bach JF, Bluestone JA, Chatenoud L.

Proc Natl Acad Sci U S A. 2007 Apr 10;104(15):6335-40. Epub 2007 Mar 26.

PMID: 17389382 [PubMed - indexed for MEDLINE]

7:

Specific antigen vaccination to treat autoimmune disease.

McDevitt H.

Proc Natl Acad Sci U S A. 2004 Oct 5;101 Suppl 2:14627-30. Epub 2004 Oct 4. Review.

PMID: 15466699 [PubMed - indexed for MEDLINE]

8:

[Principles of immunotherapy in insulin-dependent diabetes mellitus]

Bretzel RG.

Wien Klin Wochenschr. 1988 Jun 24;100(13):435-42. Review. German.

PMID: 3043913 [PubMed - indexed for MEDLINE]

9:

The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice.

Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R.

Diabetes. 2007 May;56(5):1395-402. Epub 2007 Feb 22.

PMID: 17317763 [PubMed - indexed for MEDLINE]

10:

Prevention of diabetes in the NOD mouse: implications for therapeutic intervention in human disease.

Bowman MA, Leiter EH, Atkinson MA.

Immunol Today. 1994 Mar;15(3):115-20. Review.

PMID: 8172643 [PubMed - indexed for MEDLINE]

11:

Depleting anti-CD4 monoclonal antibody cures new-onset diabetes, prevents recurrent autoimmune diabetes, and delays allograft rejection in nonobese diabetic mice.

Makhlouf L, Grey ST, Dong V, Csizmadia E, Arvelo MB, Auchincloss H Jr, Ferran C, Sayegh MH.

Transplantation. 2004 Apr 15;77(7):990-7.

PMID: 15087759 [PubMed - indexed for MEDLINE]

12:

Establishment of NOD-Pdcd1-/- mice as an efficient animal model of type I diabetes.

Wang J, Yoshida T, Nakaki F, Hiai H, Okazaki T, Honjo T.

Proc Natl Acad Sci U S A. 2005 Aug 16;102(33):11823-8. Epub 2005 Aug 8.

PMID: 16087865 [PubMed - indexed for MEDLINE]

13:

Intervention therapies for insulin-dependent diabetes.

Muir A, Schatz DA, Pozzilli P, MacLaren NK.

Autoimmunity. 1993;16(4):301-10. Review.

PMID: 8025209 [PubMed - indexed for MEDLINE]

14:

CD8+ T cell tolerance in nonobese diabetic mice is restored by insulin-dependent diabetes resistance alleles.

Martinez X, Kreuwel HT, Redmond WL, Trenney R, Hunter K, Rosen H, Sarvetnick N, Wicker LS, Sherman LA.

J Immunol. 2005 Aug 1;175(3):1677-85.

PMID: 16034108 [PubMed - indexed for MEDLINE]

15:

Lessons from the NOD mouse for the pathogenesis and immunotherapy of human type 1 (insulin-dependent) diabetes mellitus.

Lampeter EF, Signore A, Gale EA, Pozzilli P.

Diabetologia. 1989 Oct;32(10):703-8. Review.

PMID: 2687059 [PubMed - indexed for MEDLINE]

16:

Control of type 1 autoimmune diabetes by naturally occurring CD4+CD25+ regulatory T lymphocytes in neonatal NOD mice.

Piccirillo CA, Tritt M, Sgouroudis E, Albanese A, Pyzik M, Hay V.

Ann N Y Acad Sci. 2005 Jun;1051:72-87. Review.

PMID: 16126946 [PubMed - indexed for MEDLINE]

17:

Lessons on autoimmune diabetes from animal models.

Yang Y, Santamaria P.

Clin Sci (Lond). 2006 Jun;110(6):627-39. Review.

PMID: 16689681 [PubMed - indexed for MEDLINE]

18:

Dendritic cell-expanded, islet-specific CD4+ CD25+ CD62L+ regulatory T cells restore normoglycemia in diabetic NOD mice.

Tarbell KV, Petit L, Zuo X, Toy P, Luo X, Mqadmi A, Yang H, Suthanthiran M, Mojsov S, Steinman RM.

J Exp Med. 2007 Jan 22;204(1):191-201. Epub 2007 Jan 8.

PMID: 17210729 [PubMed - indexed for MEDLINE]

19:

Sex-specific effect of insulin-dependent diabetes 4 on regulation of diabetes pathogenesis in the nonobese diabetic mouse.

Ivakine EA, Fox CJ, Paterson AD, Mortin-Toth SM, Canty A, Walton DS, Aleksa K, Ito S, Danska JS.

J Immunol. 2005 Jun 1;174(11):7129-40.

PMID: 15905556 [PubMed - indexed for MEDLINE]

20:

Antigen-based immunotherapy drives the precocious development of autoimmunity.

Tian J, Olcott AP, Kaufman DL.

J Immunol. 2002 Dec 1;169(11):6564-9.

PMID: 12444168 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 173
of 9Next